Category Archives: Personalized medicine
Personalized medicine is a wide expression which completely covers a broad choice of beneficial approaches that contain diagnostic or drug combination products occuring from discoveries in the areas of pharmacogenetics, pharmacogenomics, and genetic expression. The leading number of personalized products accessible is for oncology. On the other hand, this medicine is previously being applied to lots other different ailment indications. Development of the product is promising in conditions of disease that contain autoimmune disease, autism, CNS disorders, cardiovascular, osteoarthritis, HIV infection, pain, osteoporosis, Lupus, diabetes, Renaud, Crohn and others. This type of medicine includes the classification of validation and biomarkers platforms.
The platforms of new product validation and experiment methods are noted in the areas of clinical validation, analytical validation, compliance validation, and regulatory validation, validation of benefit and validation of clinical utility. Manage, monitor, QC, QA and review promising “cutting edge” information and concepts related to data. Authoritarian scrutiny promises to be demanding in the promising field of tailored medicine. Documentation and data have to be of good and high quality. Protocol of clinical study and perfect design is difficult and rigorous, but worthwhile with statistically promising significant and clinically having an important effect patient benefits and results.